|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/12 | |
| A61K 47/20 | |||
| A61K 47/10 | |||
| A61K 31/196 | |||
| A61K 31/192 | |||
| A61P 19/02 | |||
| A61K 9/00 | |||
| A61K 31/10 | |||
| A61K 31/56 |
| (11) | Number of the document | 2544662 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11713105.2 |
| Date of filing the European patent application | 2011-03-10 | |
| (97) | Date of publication of the European application | 2013-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-20 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2011/028004 |
| Date | 2011-03-10 |
| (87) | Number | WO 2011/112875 |
| Date | 2011-09-15 |
| (30) | Number | Date | Country code |
| 312629 P | 2010-03-10 | US |
| (72) |
BUYUKTIMKIN, Servet, US
BUYUKTIMKIN, Nadir, US
KISAK, Edward T., US
SINGH, Jagat, CA
NEWSAM, John M., US
KING-SMITH, Dominic, US
GALER, Bradley S., US
|
| (73) |
Nuvo Pharmaceuticals Inc.,
7560 Airport Road, Unit 10, Mississauga, ON L4T 4H4,
CA
|
| (54) | FOAMABLE FORMULATION |
| FOAMABLE FORMULATION |